Novartis Aktie
98,72
EUR
-0,68
EUR
-0,68
%
91,55
CHF
-0,74
CHF
-0,80
%
Werbung
Novartis Aktie Analyse
07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.21 | Novartis market-perform | Bernstein Research | |
10.03.21 | Novartis buy | Deutsche Bank AG | |
09.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
|
|||
09.03.21 | Novartis buy | Jefferies & Company Inc. | |
18.02.21 | Novartis buy | UBS AG | |
18.02.21 | Novartis buy | Deutsche Bank AG | |
16.02.21 | Novartis buy | Deutsche Bank AG | |
10.02.21 | Novartis buy | Deutsche Bank AG | |
09.02.21 | Novartis buy | Deutsche Bank AG | |
03.02.21 | Novartis buy | UBS AG | |
03.02.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.01.21 | Novartis Neutral | Credit Suisse Group | |
26.01.21 | Novartis buy | UBS AG | |
26.01.21 | Novartis overweight | Morgan Stanley | |
26.01.21 | Novartis Hold | Kepler Cheuvreux | |
26.01.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.21 | Novartis buy | Jefferies & Company Inc. | |
25.01.21 | Novartis Neutral | Oddo BHF | |
22.01.21 | Novartis Underweight | Barclays Capital | |
21.01.21 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
20.01.21 | Novartis Neutral | Credit Suisse Group | |
20.01.21 | Novartis buy | Jefferies & Company Inc. | |
19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
15.01.21 | Novartis buy | Deutsche Bank AG | |
14.01.21 | Novartis buy | UBS AG | |
13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
08.01.21 | Novartis overweight | Morgan Stanley | |
04.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
21.12.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
11.12.20 | Novartis buy | Jefferies & Company Inc. | |
10.12.20 | Novartis buy | Jefferies & Company Inc. | |
27.11.20 | Novartis Underweight | Barclays Capital | |
25.11.20 | Novartis buy | UBS AG | |
25.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
24.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
10.11.20 | Novartis Underweight | JP Morgan Chase & Co. | |
02.11.20 | Novartis buy | UBS AG | |
28.10.20 | Novartis Neutral | Credit Suisse Group | |
27.10.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
27.10.20 | Novartis Underweight | Barclays Capital | |
27.10.20 | Novartis buy | Jefferies & Company Inc. | |
21.10.20 | Novartis overweight | Morgan Stanley | |
14.10.20 | Novartis buy | UBS AG | |
13.10.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung